Literature DB >> 9360541

Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects.

H Rosolova1, O Mayer, G Reaven.   

Abstract

Eighteen nondiabetic volunteers were selected for these studies on the basis of their plasma magnesium (Mg) concentrations defined as being either high (> 0.83 mmol/L) or low (< 0.80 mmol/L). Although different in Mg concentration (0.90 +/- 0.02 vs. 0.73 +/- 0.01 mmol/L), the 2 groups were comparable in terms of age, gender distribution, body mass index, and waist to hip girth. Measurements were made of their plasma glucose and insulin concentrations in response to a 75-g oral glucose load and the steady state plasma insulin and glucose (SSPG) concentrations at the end of an 180-min infusion of octreotide, insulin, and glucose. The low Mg group had significantly higher plasma glucose (P < 0.001) and insulin (P < 0.002) concentrations after the oral glucose challenge. Although the steady state plasma insulin concentrations were similar during the infusion study, the SSPG concentration was significantly (P < 0.001) greater in the low Mg group (11.9 +/- 0.9 vs. 6.6 +/- 0.9 mmol/L). Finally, when the 18 patients were analyzed together, there were significant (P < 0.05 to P < 0.01) inverse correlations between Mg concentrations and glucose (r = -0.68) and insulin (r = -0.51) areas and SSPG concentrations (r = -0.60). Thus, a low Mg concentration in nondiabetic subjects was associated with relative insulin resistance, glucose intolerance, and hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360541     DOI: 10.1210/jcem.82.11.4370

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

Review 1.  The use of selected nutrition supplements and complementary and alternative medicine in liver disease.

Authors:  A James Hanje; Brett Fortune; Ming Song; Daniell Hill; Craig McClain
Journal:  Nutr Clin Pract       Date:  2006-06       Impact factor: 3.080

2.  Regulation of heart insulin receptor tyrosine kinase activity by magnesium and spermine.

Authors:  Ralph Paxton; Lingxiang Ye
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

3.  Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study.

Authors:  Raquel Villegas; Yu-Tang Gao; Qi Dai; Gong Yang; Hui Cai; Honglan Li; Wei Zheng; Xiao Ou Shu
Journal:  Am J Clin Nutr       Date:  2009-02-18       Impact factor: 7.045

4.  Consumption and acceptability of whole grain staples for lowering markers of diabetes risk among overweight and obese Tanzanian adults.

Authors:  Alfa Muhihi; Dorothy Gimbi; Marina Njelekela; Emmanuel Shemaghembe; Kissah Mwambene; Faraja Chiwanga; Vasanti S Malik; Nicole M Wedick; Donna Spiegelman; Frank B Hu; Walter C Willett
Journal:  Global Health       Date:  2013-06-23       Impact factor: 4.185

5.  Adequate magnesium level as an associated factor of pre-diabetes and diabetes mellitus remission in patients with obesity submitted to bariatric surgery.

Authors:  Vanessa Guerreiro; Isabel Maia; João Sérgio Neves; Daniela Salazar; Maria João Ferreira; Fernando Mendonça; Maria Manuel Silva; Sara Viana; Cláudia Costa; Jorge Pedro; Ana Varela; Eva Lau; Paula Freitas; Davide Carvalho
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

6.  Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study.

Authors:  Maria de Lourdes Lima de Souza E Silva; Thomaz Cruz; Luiz Erlon Rodrigues; Ana Marice Ladeia; Olivia Bomfim; Lucas Olivieri; Juliana Melo; Raquel Correia; Mirna Porto; Alexandre Cedro
Journal:  J Clin Med Res       Date:  2014-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.